Paul Falk
- Hepatology top 2%
- Epidemiology top 10%
- Molecular Biology
- Organic Chemistry top 10%
- Infectious Diseases top 5%
- Co-authors
- Hsu‐Tso HoFiona McPheeDennis HernandezJoanne J. BronsonJames G. RobertsonAnn W. WalshMichael J. PucciKerry M. Ervin
- Topics
- Hepatitis C virus research (9 papers)HIV/AIDS drug development and treatment (7 papers)Hepatitis B Virus Studies (6 papers)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Paul Falk
20 papers receiving 869 citations
Peers
Comparison fields: 5 of 61
- Hepatology 344
- Epidemiology 316
- Molecular Biology 277
- Organic Chemistry 251
- Infectious Diseases 244
Countries citing papers authored by Paul Falk
This map shows the geographic impact of Paul Falk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Falk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Falk more than expected).
Fields of papers citing papers by Paul Falk
This network shows the impact of papers produced by Paul Falk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Falk. The network helps show where Paul Falk may publish in the future.
Co-authorship network of co-authors of Paul Falk
This figure shows the co-authorship network connecting the top 25 collaborators of Paul Falk. A scholar is included among the top collaborators of Paul Falk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Falk. Paul Falk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 18 | |
| 4 | 98 | |
| 5 | 86 | |
| 6 | 139 | |
| 7 | 2 | |
| 8 | 10 | |
| 9 | 13 | |
| 10 | 1 | |
| 11 | 8 | |
| 12 | 76 | |
| 13 | 201 | |
| 14 | 36 | |
| 15 | 63 | |
| 16 | 29 | |
| 17 | Physical characterizations of E coli UDP-N-acetylmuramateL-alanine ligase | 1 |
| 18 | 33 | |
| 19 | 26 | |
| 20 | 53 |
About Paul Falk
Paul Falk is a scholar working on Hepatology, Biochemistry and Infectious Diseases, having authored 20 papers that have together received 896 indexed citations. Recurring topics across this work include Hepatitis C virus research (9 papers), HIV/AIDS drug development and treatment (7 papers) and Hepatitis B Virus Studies (6 papers). The work is most often cited by research in Hepatology (344 citations), Infectious Diseases (244 citations) and Molecular Medicine (56 citations). Paul Falk has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Hsu‐Tso Ho, Fiona McPhee, Dennis Hernandez, Joanne J. Bronson, James G. Robertson, Ann W. Walsh, Michael J. Pucci, Kerry M. Ervin, Jacques Friborg and Jane A. Thanassi. Their work appears in journals such as Hepatology, Biochemistry and The FASEB Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.